Joint Formulary & PAD

Apraclonidine - Glaucoma / ocular hypertension

You are here : Home > Formulary Search > Apraclonidine - Glaucoma / ocular hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Eye drops
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Apraclonidine
Indication :
Glaucoma / ocular hypertension
Group Name :
Keywords :
chronic glaucoma
Brand Names Include :
Iopidine
Important Information :

Licensed product has been discontinued. Unlicensed products are available but use is now unlicensed.

0.5% drops for short-term adjunctive treatment of chronic glaucoma. In exceptional circumstances it may be necessary for an additional bottle to be prescribed by the GP e.g. where a patient has been unable to apply accurate doses and has run out prior to finishing the required duration of treatment.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Glaucoma / ocular hypertension
Supporting Documents :
0

Committee Recommendations (1)

02 Oct 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Apraclonidine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Glaucoma / ocular hypertension.